Quent Capital, LLC Novo Cure LTD Transaction History
Quent Capital, LLC
- $912 Million
- Q1 2025
A detailed history of Quent Capital, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Quent Capital, LLC holds 59 shares of NVCR stock, worth $1,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 76
22.37%
Holding current value
$1,062
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$203 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$161 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$99.4 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$93.9 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.89B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...